Over 14 Million People in U.S. Cite Upper Arm Fat as Troubling
Company Announces Upcoming Launch of New CoolAdvantage™ Petite Applicator, Designed to Optimize CoolSculpting Performance in Upper Arms
PLEASANTON, Calif., Jan. 26, 2017 (GLOBE NEWSWIRE) — ZELTIQ® Aesthetics, Inc. (ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology, today announced that CoolSculpting® is FDA-cleared for upper arms, making it the only non-invasive fat removal technology cleared by the FDA to address this body area.
“There are 29 million people in the U.S. interested in CoolSculpting, with more than 14 million expressing concern about unwanted arm fat, making arms the third most popular area for consideration of non-invasive fat reduction,” said Mark Foley, President and Chief Executive Officer of ZELTIQ. “As demonstrated with our recent FDA clearance, we are committed to investing in R&D and clinical research to provide consumers with solutions that they desire most. CoolSculpting’s ability to successfully treat upper arm fat is a testament to our technology’s efficacy and versatility, as well as our position as the market leader in non-invasive fat reduction.”
Chevy Chase CoolSculpting
The company also announced that it will be launching the CoolAdvantage Petite applicator for the CoolSculpting system in order to optimize the performance of CoolSculpting in the upper arms, with full commercial release targeted for the middle part of the year. The newest member of the CoolAdvantage family of applicators, the CoolAdvantage Petite treatment comes with two interchangeable contours designed to uniquely treat the upper arm area in just 35 minutes.
“My patients have been asking for a non-invasive solution for their unwanted arm fat so I am thrilled to be able to offer them a proven solution that is safe and effective,” said Grant Stevens, MD, FACS, Founder and Medical Director of Marina Plastic Surgery and Medical Director of Body by OrangeTwist. “We anticipate a lot of interest from our patients now that there is an FDA-cleared solution to treat this challenging area.”
CoolSculpting is a safe and effective treatment for non-invasive fat reduction with unmatched clinical evidence. With more than 70 peer-reviewed clinical papers and abstracts and over 3.5 million treatments performed to date in over 80 countries around the world, CoolSculpting is the clear market leader in non-invasive fat reduction. CoolSculpting is FDA-cleared for the treatment of fat bulges in the submental area, thigh, abdomen, flank, bra and back fat area, underneath the buttocks and now, the upper arm.
CoolSculpting is available at The West Institute in Chevy Chase, MD.